PATENT CLAIM ANALYSIS

Application Number: 15773798
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "170000"]

Abstract:
The present invention relates to the use of non-bioconvertible C 3 -substituted pregnenolone derivatives of formula (I), with no significant affinity for hormonal receptors or receptors of the central nervous system, in the treatment of substance use disorders, and in particular of alcohol use disorder.

Claim (Index 5):
The method of  claim 2 , wherein R 2  is \u2014CO\u2014.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 93.0
- Lexical Diversity: 1.30769
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15444778', '15012471', '14950178', '13666663', '12232993']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7819788015815993
- 35 USC 102 Novelty (BERT): 0.5332897922043148
- Combined Prediction Score: 0.7571099006438708
- Mean Citation Score: 276.51452800000004
- Max Citation Score: 335.08203
- Similarity Product: 161.9581972358501

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test